Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis
- PMID: 15100315
- DOI: 10.4049/jimmunol.172.9.5702
Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis
Abstract
Complement activation is involved in the initiation of Ab-mediated inflammatory demyelination in experimental autoimmune encephalomyelitis (EAE). At a sublytic dose, the C5b-9 membrane attack complex protects oligodendrocytes (OLG) from apoptosis. Using C5-deficient (C5-d) mice, we previously showed a dual role for C5: enhancement of inflammatory demyelination in acute EAE, and promotion of remyelination during recovery. In this study, we investigated the role of C5 in apoptosis in myelin-induced EAE. In acute EAE, C5-d and C5-sufficient (C5-s) mice had similar numbers of total apoptotic cells, whereas C5-s had significantly fewer than C5-d during recovery. In addition, although both groups of mice displayed TUNEL(+) OLG, there were significantly fewer in C5-s than in C5-d during both acute EAE and recovery. Gene array and immunostaining of apoptosis-related genes showed that Fas ligand expression was higher in C5-s. In C5-s mice, Fas(+) cells were also higher than in C5-d mice in acute EAE; however, these cells were significantly reduced during recovery. Together, these findings are consistent with the role of C5, possibly by forming the membrane attack complex, in limiting OLG apoptosis in EAE, thus promoting remyelination during recovery.
Similar articles
-
Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis.Ann N Y Acad Sci. 2003 Dec;1010:530-3. doi: 10.1196/annals.1299.098. Ann N Y Acad Sci. 2003. PMID: 15033785
-
Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis.Am J Pathol. 2003 Sep;163(3):1069-80. doi: 10.1016/S0002-9440(10)63466-9. Am J Pathol. 2003. PMID: 12937147 Free PMC article.
-
C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection.Ann Med. 2005;37(2):97-104. doi: 10.1080/07853890510007278. Ann Med. 2005. PMID: 16026117 Review.
-
Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.J Neuroimmunol. 2009 Aug 18;213(1-2):3-11. doi: 10.1016/j.jneuroim.2009.06.006. Epub 2009 Jul 4. J Neuroimmunol. 2009. PMID: 19577811 Free PMC article. Review.
-
Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.J Immunol. 2010 Dec 15;185(12):7646-53. doi: 10.4049/jimmunol.1000930. Epub 2010 Nov 10. J Immunol. 2010. PMID: 21068410
Cited by
-
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review.Front Mol Neurosci. 2022 Oct 13;15:1017484. doi: 10.3389/fnmol.2022.1017484. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36311030 Free PMC article. Review.
-
The role of the complement system in innate immunity.Immunol Res. 2005;33(2):103-12. doi: 10.1385/IR:33:2:103. Immunol Res. 2005. PMID: 16234578 Review.
-
The role of the complement system in Multiple Sclerosis: A review.Front Immunol. 2022 Aug 10;13:970486. doi: 10.3389/fimmu.2022.970486. eCollection 2022. Front Immunol. 2022. PMID: 36032156 Free PMC article. Review.
-
Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank.Psychol Med. 2021 Mar 3;52(15):1-11. doi: 10.1017/S0033291721000179. Online ahead of print. Psychol Med. 2021. PMID: 33653435 Free PMC article.
-
Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis.Exp Mol Pathol. 2007 Oct;83(2):198-206. doi: 10.1016/j.yexmp.2007.05.006. Epub 2007 Jul 6. Exp Mol Pathol. 2007. PMID: 17662270 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous